Can Hepatitis B Virus (HBV) Reactivation Result from a Mild COVID-19 Infection?
Hepatitis B virus reactivation (HBVr) is a well-described result of immunosuppressive therapy initiation in various diseases, with the dose and duration of treatment being the main factors determining the probability for reactivation. Such cases have also been described in COVID-19 patients treated...
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
MDPI AG
2023-07-01
|
| Edice: | Livers |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2673-4389/3/3/26 |